17% quarter-over-quarter growth with record VINIA® global sales orders in Q4 of USD 825k 485% year-over-year growth with total sales orders of USD 2.4M in 2021...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – December 30, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (“BioHarvest” or the “Company”) is pleased to...
Cannabis produced has a Trichomes density of up to 200 times greater than in a plant-grown product while solving major industry challenges of consistency, safety, and...
The new factory is ready to start production to meet the increased demand for VINIA® On track for the conversion of the existing 2 tons/year facility...
New research analysis affirms the addition of the following structure function claims for VINIA® according to FDA Guidelines for Dietary Supplements: VINIA® prevents Lipid Oxidation VINIA®...
Steven Lehrer’s 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D. His appointment continues to demonstrate the...
David Tsur’s 40 years of Biotech experience further strengthens the Board at a critical phase of the Company’s growth His appointment reinforces the Company’s primary focus...
Vancouver, Canada, and Rehovot, Israel–(Newsfile Corp. – October 13, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) (“BioHarvest” or the “Company”) today announces an update...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – October 12, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) (“BioHarvest” or the “Company”) invites its shareholders and...
Total of CAD$ 7,909,064 raised from private placement and warrants exercised Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – October 4, 2021) – BioHarvest Sciences Inc. (CSE:...